SMTISanara MedTech Inc.

Nasdaq sanaramedtech.com


$ 33.19 $ 0.26 (0.79 %)    

Wednesday, 08-May-2024 15:49:49 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 33.12
$ 32.52
$ 0.00 x 0
$ 33.29 x 100
$ 32.52 - $ 33.19
$ 26.06 - $ 46.40
3,996
na
274.2M
$ -8.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-25-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-20-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-30-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-30-2021 12-31-2020 10-K
14 11-13-2020 09-30-2020 10-Q
15 08-13-2020 06-30-2020 10-Q
16 05-12-2020 03-31-2020 10-Q
17 03-26-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-20-2019 03-31-2019 10-Q
21 04-01-2019 12-31-2018 10-K
22 11-14-2018 09-30-2018 10-Q
23 08-13-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 03-29-2018 12-31-2017 10-K
26 11-16-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-15-2017 03-31-2017 10-Q
29 04-04-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
31 08-11-2016 06-30-2016 10-Q
32 05-16-2016 03-31-2016 10-Q
33 04-14-2016 12-31-2015 10-K
34 11-13-2015 09-30-2015 10-Q
35 08-17-2015 06-30-2015 10-Q
36 05-15-2015 03-31-2015 10-Q
37 04-09-2015 12-31-2014 10-K
38 11-13-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-15-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cantor-fitzgerald-maintains-overweight-on-sanara-medtech-lowers-price-target-to-44

Cantor Fitzgerald analyst Ross Osborn maintains Sanara MedTech (NASDAQ:SMTI) with a Overweight and lowers the price target f...

 sanara-medtech-q4-eps-003-beats-013-estimate-sales-1769m-beat-1650m-estimate

Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.13...

 earnings-scheduled-for-march-25-2024

Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on re...

 cantor-fitzgerald-reiterates-overweight-on-sanara-medtech-maintains-49-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates Sanara MedTech (NASDAQ:SMTI) with a Overweight and maintains $49 price target.

 sanara-medtech-announced-that-is-has-signed-an-exclusive-license-agreement-with-tufts-university-to-develop-and-commercialize-patented-technology-covering-18-unique-collagen-peptides

As part of this agreement, Sanara has formed a new subsidiary, Sanara Collagen Peptides, LLC ("SCP"), and has issued 10...

 sanara-medtech-inc-announces-the-publication-of-a-5335-patient-study-demonstrating-a-significant-reduction-in-surgical-site-infections-when-activated-collagen-celleraterx-surgical-powder-was-used-to-promote-wound-healing

Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," ...

 cantor-fitzgerald-maintains-overweight-on-sanara-medtech-lowers-price-target-to-49

Cantor Fitzgerald analyst Ross Osborn maintains Sanara MedTech (NASDAQ:SMTI) with a Overweight and lowers the price target f...

 sanara-medtech-q3-eps-013-up-from-018-yoy-sales-1602m-miss-1880m-estimate

Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(0.13) per share. This is a 27.78 percent increase over losses of $(...

 earnings-scheduled-for-november-13-2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

 cantor-fitzgerald-reiterates-overweight-on-sanara-medtech-maintains-59-price-target

Cantor Fitzgerald analyst Brandon Folkes reiterates Sanara MedTech (NASDAQ:SMTI) with a Overweight and maintains $59 price t...

 cantor-fitzgerald-reiterates-overweight-on-sanara-medtech-maintains-59-price-target

Cantor Fitzgerald analyst Brandon Folkes reiterates Sanara MedTech (NASDAQ:SMTI) with a Overweight and maintains $59 price t...

 cantor-fitzgerald-reiterates-overweight-on-sanara-medtech-maintains-59-price-target

Cantor Fitzgerald analyst Brandon Folkes reiterates Sanara MedTech (NASDAQ:SMTI) with a Overweight and maintains $59 price t...

 sanara-medtech-q2-eps-022-misses-013-estimate-sales-1575m-miss-1690m-estimate

Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0....

 earnings-scheduled-for-august-14-2023

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per ...

 sanara-medtech-inc-announces-the-acquisition-of-certain-assets-related-to-its-collagen-products-business-the-initial-purchase-price-for-the-assets-that-were-acquired-by-the-company-is-1525m

Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION